Medco Liberty Medical Unit Face Deceptive-Practices Suit
The News Review:
- Medco Liberty Medical Unit Face Deceptive-Practices Suit
- Cholesterol Drugs Cut Risk of Clots Too
- CardioNet Restructures and Expands Medical Advisory Board
- Santa Cruz medical pot outfit on the brink of survival
- BioForm Medical Strengthens Its Board of Directors With Three …
- Vanderbilt Medical chief to retire in June
Medco Liberty Medical Unit Face Deceptive-Practices Suit
CNNMoney.com
(MHS) and its LibertyMedical diabetic supply business of engaging in deceptive practices and unfaircompetition. In a lawsuit filed last week in U. District Court in Nashville AmMed DirectLLC a Tennessee-based company that provides home delivery of diabetic suppliesand medications alleges that Medco and Liberty have caused it irreparable harmand damage.
Cholesterol Drugs Cut Risk of Clots Too
WebMD
But many people can’t take Coumadin for medical reasons including an increased risk of bleeding. In contrast statins carry “no bleeding hazard at all” says JUPITER trial chairman Paul Ridker MD a cardiologist at Brigham and Women’s Hospital in Boston. While no one is sure exactly how statins lower clot risk Glynn says they may act as an anticoagulant. Claudio Schuger MD a heart specialist at Wayne State University in Detroit says that while only Crestor was studied other statin drugs probably also confer protection against VTE. Schuger was co-chair of the committee that chose which studies to highlight at the meeting.
CardioNet Restructures and Expands Medical Advisory Board
FXBusiness
Medical Director and Chairman of CardioNet’s Medical Advisory Board said “The CardioNet Medical Advisory Board is a highly talented group of physicians. Their diverse expertise will help us to continue to advance the technology beyond what CardioNet is today to benefit even more patients with cardiovascular disease. I am excited to chair this extraordinary group. Randy Thurman Chairman President and Chief Executive fficer of CardioNet said “We are very pleased to welcome the new members of our Medical Advisory Board. ur Medical Advisory Board will be instrumental in the achievement of CardioNet’s strategic imperatives as well as our mission to become the leader in wireless medicine.
Santa Cruz medical pot outfit on the brink of survival
San Jose Mercury News
The bama administration through new Attorney General Eric Holder has publicly indicated in recent weeks that it will not enforce federal drug laws against medical marijuana providers in states with medical pot laws as long as those providers are obeying their state laws. For WAMM’s leaders and patients such a policy shift would not only end their 6-year-old lawsuit but also an era of raids uncertainty and near-extinction for an operation that tends to the sick and dying. The Santa Cruz case also could be the first in the country that forces the new administration to lay out its exact policy on medical pot in writing.
BioForm Medical Strengthens Its Board of Directors With Three …
FXBusiness
Chris Dennis former Global President of rthoNeutrogena joined the Board of Directors in December 2008. Jeff Nugent former CE of Revlon and former Worldwide President and CE of Neutrogena joined the Board of Directors in February 2009. In addition Dennis Condon currently BioForm Medical’s President and Chief Business fficer and formerly a member of BioForm Medical’s Board of Directors has rejoined the Board of Directors in March 2009. In evaluating and proposing nominees for election to the Board BioForm Medical’s Nominating and Corporate Governance Committee has guided the Board of Directors’ transition from a predominantly venture capital-led to one led by industry veterans. Pursuant to this initiative Jeff Nugent has replaced Dr. Albert Cha a Managing Partner at Vivo Ventures an early BioForm Medical investor and Chris Dennis has replaced Dr. Evan Melrose a Managing Partner of PTV Sciences also an early BioForm Medical investor.
Related from Allgulfvets: BioForm Medical Strengthens Its Board of Directors With Three …
Vanderbilt Medical chief to retire in June
Bizjournals.com
Harry Jacobson is exiting his post as vice chancellor for health affairs at. In a statement Vanderbilt says Jacobson is retiring. Jacobson came to Vanderbilt in 1985 as professor of medicine and director of the nephrology division and has held the vice chancellor position since 1997. “Under his leadership Vanderbilt has become the premier health care institution in our region and is recognized as one of the best in the country” Zeppos said in a statement.
Written by admin on March 31st, 2009 with
no comments.
Read more articles on News.